Effects of oral testosterone undecanoate therapy on bone mineral density and body composition in 322 aging men with symptomatic testosterone deficiency: a 1-year, randomized, placebo-controlled, dose-ranging study
Effects of oral testosterone undecanoate therapy on bone mineral density and body composition in 322 aging men with symptomatic testosterone deficiency: a 1-year, randomized, placebo-controlled, dose-ranging study
复制标题
DOI：
10.3109/13685538.2013.773420
复制
发表时间：
2013-06-01
期刊：
影响因子：
2.6
通讯作者：
Meuleman, Eric J. H.
中科院分区：
文献类型：
--
作者：
Bouloux, Pierre M. G.;Legros, Jean-Jacques;Meuleman, Eric J. H.
目的：我们研究口服十一酸睾酮 (TU) 对有症状睾酮缺乏 (TD) 的老年男性骨矿物质密度 (BMD)、去脂体重 (LBM) 和体脂量 (BFM) 的影响。方法：对 322 名 TD 症状 >= 50 岁的男性进行计算，并计算游离睾酮
Objective: We investigated the effects of oral testosterone undecanoate (TU) on bone mineral density (BMD), lean body mass (LBM) and body fat mass (BFM) in aging men with symptomatic testosterone deficiency (TD).Methods: Three hundred twenty-two men >= 50 years with TD symptoms and calculated free testosterone